Spyre Therapeutics
SYRE
SYRE
64 hedge funds and large institutions have $155M invested in Spyre Therapeutics in 2018 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 22 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.66% more ownership
Funds ownership: 2.03% → 2.69% (+0.66%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
64
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.44M | |
| 2 | +$6.78M | |
| 3 | +$5.39M | |
| 4 |
Renaissance Technologies
New York
|
+$4.51M |
| 5 |
Millennium Management
New York
|
+$4.26M |
Top Sellers
| 1 | -$1.95M | |
| 2 | -$649K | |
| 3 | -$188K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$183K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$158K |